Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Financial Flexibility Index
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥85.65 Million (operating CF CN¥61.35 Million minus capex CN¥24.30 Million) represents 0% of total liabilities (CN¥692.94 Million). Check Chengdu Easton Biopharmaceuticals Co Ltd (688513) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chengdu Easton Biopharmaceuticals Co Ltd Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Chengdu Easton Biopharmaceuticals Co Ltd across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Chengdu Easton Biopharmaceuticals Co Ltd.
Annual Financial Flexibility Index for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2024)
Year-by-year free cash flow to debt coverage for Chengdu Easton Biopharmaceuticals Co Ltd. Explore Chengdu Easton Biopharmaceuticals Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | CN¥380.66 Million | CN¥263.24 Million | CN¥702.21 Million | ▼ -10.6% |
| 2023 | 0.61x | CN¥450.51 Million | CN¥275.25 Million | CN¥743.33 Million | ▼ -29.3% |
| 2022 | 0.86x | CN¥491.27 Million | CN¥151.94 Million | CN¥573.08 Million | ▲ +2.6% |
| 2021 | 0.84x | CN¥403.89 Million | CN¥147.60 Million | CN¥483.60 Million | ▲ +2.4% |
| 2020 | 0.82x | CN¥355.33 Million | CN¥156.52 Million | CN¥435.61 Million | ▼ -0.4% |
| 2019 | 0.82x | CN¥237.24 Million | CN¥141.83 Million | CN¥289.64 Million | ▼ -30.2% |
| 2018 | 1.17x | CN¥243.42 Million | CN¥166.79 Million | CN¥207.50 Million | ▲ +58.3% |
| 2017 | 0.74x | CN¥108.72 Million | CN¥85.70 Million | CN¥146.70 Million | ▼ -22.0% |
| 2016 | 0.95x | CN¥123.88 Million | CN¥106.06 Million | CN¥130.43 Million | ▼ -52.0% |
| 2015 | 1.98x | CN¥86.00 Million | CN¥50.57 Million | CN¥43.42 Million | ▲ +130.1% |
| 2014 | 0.86x | CN¥68.75 Million | CN¥46.71 Million | CN¥79.85 Million | ▼ -28.8% |
| 2013 | 1.21x | CN¥104.23 Million | CN¥28.12 Million | CN¥86.24 Million | — |